NCT07086716 Frailty in Hip or Knee Arthroplasty Patients.
| NCT ID | NCT07086716 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Joel Pollet |
| Condition | Frail Elderly |
| Study Type | OBSERVATIONAL |
| Enrollment | 124 participants |
| Start Date | 2025-06-03 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 124 participants in total. It began in 2025-06-03 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study aims to understand the existing differences between frail and non-frail subjects who underwent a rehabilitation path after receiving hip or knee arthroplasty surgery.
Eligibility Criteria
Inclusion Criteria: * Received elective hip or knee arthroplasty; * Ability to understand written and oral instructions; * Gave consent to study participation. Exclusion Criteria: * Arthroplasty revision or not elective intervention; * Participation in other studies; * Hospitalized in the rehabilitation ward more then 10 days after surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07086716 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Frail Elderly. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07086716 currently recruiting?
Yes, NCT07086716 is actively recruiting participants. Contact the research team at jpollet@dongnocchi.it for enrollment information.
Where is the NCT07086716 trial being conducted?
This trial is being conducted at Rovato, Italy.
Who is sponsoring the NCT07086716 clinical trial?
NCT07086716 is sponsored by Joel Pollet. The trial plans to enroll 124 participants.